$Effect of extended-release metformin on humoral cardiometabolic markers and lipid peroxidation parameters in patients with prediabetes, heart failure with preserved ejection fraction and abdominal obesity$

Effect of extended-release metformin on humoral cardiometabolic markers and lipid peroxidation parameters in patients with prediabetes, heart failure with preserved ejection fraction and abdominal obesity

Aim. To study the effect of extended-release (XR) metformin on humoral cardiometabolic markers and lipid peroxidation parameters in patients with heart failure with preserved ejection fraction (HFpEF), prediabetes and abdominal obesity (AO).Material and methods. The study included 64 people (men – 5...

Full description

Saved in:

Bibliographic Details
Main Authors:	O. V. Tsygankova, N. E. Apartseva, L. D. Latyntseva, Ya. V. Polonskaya, E. V. Kashtanova
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2024-08-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	metformin xr heart failure with preserved ejection fraction prediabetes abdominal obesity nt-probnp sst2 high-sensitivity c-reactive protein malondialdehyde
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/4100
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Extended-release metformin in patients with prediabetes, chronic heart failure and abdominal obesity in light of the effect on fat depot compartments and glucose metabolism parameters
by: O. V. Tsygankova, et al.
Published: (2024-09-01)

Level and correlations of soluble suppression of tumorigenicity 2 protein in heart failure and its relationship with clinical and paraclinical characteristics of patients
by: A. Ya. Kravchenko, et al.
Published: (2022-06-01)

Diagnostic Significance of the Level of Soluble Stimulating Growth Factor in Patients with Spondyloarthritis as an Early Marker of Cardiovascular Pathology
by: K. D. Dorogoykina, et al.
Published: (2022-05-01)

Changes of NT-proBNP and sST2 levels for predicting isolated episodes of ventricular tachyarrhythmias and electrical storm in patients with systolic heart failure and various implanted devices
by: A. Zh. Gasparyan, et al.
Published: (2020-12-01)

Potential of NT-proBNP and sST2 rapid tests in patients with acute myocardial infarction
by: V. V. Ryabov, et al.
Published: (2023-07-01)

Prognostic significance of NT-proBNP and sST2 biomarkers in patients with post-myocardial infarction heart failure after a coronavirus infection
by: N. M. Kalashnikova, et al.
Published: (2023-07-01)

Insulin resistance and heart failure with preserved ejection fraction. Pathogenetic and therapeutic crossroads
by: O. V. Tsygankova, et al.
Published: (2023-01-01)

Effect of spironolactone on transmitral diastolic blood flow and course of chronic heart failure with preserved left ventricular ejection fraction
by: V. A. Vasylenko
Published: (2015-10-01)

Diagnostic value of cardiac marker concentrations in patients with heart failure depending on frailty syndrome
by: V. A. Safronenko, et al.
Published: (2024-10-01)

Prognostic significance of a combination of novel biomarkers in the long-term stratification of adverse outcomes in patients with ST-segment elevation myocardial infarction
by: D. F. Gareeva, et al.
Published: (2020-12-01)

Prognostic biomarker soluble ST2 exhibits diurnal variation in chronic heart failure patients
by: Sandra Crnko, et al.
Published: (2020-06-01)

Investigating the diagnostic accuracy of vertebral heart score, vertebral left atrium score and thoracic width measurement in cats with suspected cardiac problems
by: B. Ozdil, et al.
Published: (2025-03-01)

Prediabetes: problems of diagnostics and treatment of initial carbohydrate metabolism disorders in real-world practice (data from the PROFILE outpatient registry)
by: Yu. V. Lukina, et al.
Published: (2025-05-01)

Impact of obesity on echocardiographic parameters and N-terminal pro-brain natriuretic peptide levels in patients with heart failure with mid-range ejection fraction: unanswered questions
by: E. A. Lyasnikova, et al.
Published: (2021-07-01)

Comprehensive exploration of unexplained dyspnoea in subjects with normal ejection fraction and low natriuretic peptides
by: Emmanuelle Berthelot, et al.
Published: (2025-04-01)

Modern Aspects of the Clinic, Diagnosis and Treatment of Prediabetes
by: N. V. Pyrikova, et al.
Published: (2020-10-01)

Relationships between the activity of neurohormonal systems and intracardiac hemodynamics in patients with heart failure: focus on galectin-3
by: V. I. Podzolkov, et al.
Published: (2022-05-01)

Importance of NT-pro BNP in the Prevention of Heart Failure, Left Ventricular Systolic Dysfunction and Cardiovascular Events
by: Irina CUCIUREANU, et al.
Published: (2021-06-01)

Growth differentiation factor‐15 and N‐terminal pro‐BNP in acute heart failure with preserved ejection fraction
by: Yoichiro Otaki, et al.
Published: (2025-04-01)

Levels of sST2 and NT-proBNP biomarkers in patients with acute coronary syndrome and subclinical hypothyroidism
by: N. B. Kuz, et al.
Published: (2024-05-01)

BIOMARKERS OF MYOCARDIAL STRESS AND FIBROSIS FOR CLINICAL OUTCOMES ASSESSMENT IN POST MYOCARDIAL INFARCTION HEART FAILURE PATIENTS
by: N V Shilyaeva, et al.
Published: (2018-03-01)

Assessment of N-terminal pro-brain natriuretic peptide in patients with arrhythmia due to undifferentiated connective tissue disease
by: E. N. Loginova, et al.
Published: (2023-11-01)

Characteristics of patients with chronic heart failure in different age groups
by: R. I. Jafarov, et al.
Published: (2023-05-01)

Lower NT‐proBNP plasma concentrations in Pacific peoples with heart failure
by: Andree G. Pearson, et al.
Published: (2025-08-01)

N-terminal pro-B-type natriuretic peptide as a predictive marker of the outcomes of fibrinolytic therapy in acute ST-elevation myocardial infarction
by: Amit Kumar, et al.
Published: (2024-04-01)

Chronic Heart Failure in Early Rheumatoid Arthritis Patients Prior to Basic Antirheumatic Therapy
by: I. G. Kirillova, et al.
Published: (2020-03-01)

Time course of changes in the level of N-terminal pro-brain natriuretic peptide (NT-proBNP) in patients with rheumatoid arthritis during therapy with an interleukin-6 receptor inhibitor
by: E. V. Gerasimova, et al.
Published: (2019-11-01)

Risk prediction in acute coronary syndrome depending on the types of myocard revascularization
by: R. V. Denina
Published: (2016-12-01)

PREDICTORS OF CONTINUOUS HOSPITAL STAY IN ADULT PATIENTS WITH ACQUIRED VALVULAR DISEASE, OPERATED WITH HYPOTHERMIC AND NORMOTHERMIC CARDIOPULMONARY BYPASS
by: D. G. Shakhin, et al.
Published: (2017-12-01)

IMPACT OF ANTIRHEUMATIC THERAPY ON THE LEVEL OF N-TERMINAL PRO-BRAIN NATRIURETIC PEPTIDE IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS
by: I. G. Kirillova, et al.
Published: (2018-07-01)

Prognostic and diagnostic significance of the cardiac biomarker NT-proBNP in the perioperative period of vascular surgery procedures
by: I. A. Kozlov, et al.
Published: (2023-10-01)

Pre-diabetes as an interdisciplinary problem: definition, risks, approaches to the diagnostics and prevention of type 2 diabetes and cardiovascular complications
by: O. L. Barbarash, et al.
Published: (2019-05-01)

NT-proBNP for Heart Failure Screening in Primary Care in an Eastern European Country: What We Know and Proposed Steps
by: Ioana Camelia Teleanu, et al.
Published: (2025-01-01)

N- terminal pro brain natriuratic peptide (nt-probnp) in apparently healthy subjects compared to metabolic syndrome subjects
by: Zaidan Azeez Hasan, et al.
Published: (2022-06-01)

N-terminal pro-brain natriuretic peptide as a predictive marker of short-term mortality in sepsis
by: Amit Kumar, et al.
Published: (2025-04-01)

Associations of NT-proBNP and hepcidin levels with clinical and laboratory parameters in patients with heart failure with various severity of left ventricular systolic dysfunction
by: V. I. Podzolkov, et al.
Published: (2020-09-01)

Effect of metformin on the level of aqueous humor inflammatory cytokines in patients with cataract
by: Jiaxi Li, et al.
Published: (2025-01-01)

PARALLELS BETWEEN THE HEMODYNAMIC PROFILE AND BIOMARKERS ACTIVITY IN DIFFERENT FORMS OF ACUTE HEART FAILURE IN THE EARLY PERIOD AFTER AORTOCORONARY BYPASS
by: D. A. Laletin, et al.
Published: (2017-11-01)

Pharmacoepidemiological analysis of therapy for chronic heart failure
by: D. D. Monakhova, et al.
Published: (2023-09-01)

N-TERMINAL PRO-BRAIN NATRIURETIC PEPTIDE IN DIAGNOSTICS OF NON-COMPACTED MYOCARDIUM IN CHILDREN
by: E. N. Arkhipova, et al.
Published: (2012-10-01)